Services

Chemical design

NewDrug undertakes the design of potential active peptides or mimetics based on ligand–receptor interactions. Subsequently, in silico predictive studies are performed for the identification of new bioactives. The ultimate goal is in-depth analysis to find the best possible analogues for drug development and immunomodulation.

Peptide TechnologyCustom Peptides Synthesis

NewDrug’s peptide chemists design and synthesize peptides in small and large scale. We synthesize by subcontracting services high yield of linear and cyclic peptides using conventional or microwave methods in solid phase.

Organic Synthesis

NewDrug provides specific Medicinal Chemistry services for drug development process. Our subcontracting Medicinal Chemists undertake synthesis of scaffolds and organic molecules (small scale, non GMP synthesis for research purposes).

Analytical services

We offer – through subcontracting services within our network – chromatographic analyses (HPLC, UPLC-MS/MS) services specializing particularly in the analysis and identification of peptides and organic molecules (Physical and Chemical Characterization, Stability studies, Pharmacokinetics studies, Method Development and Validation, Consulting services in Drug Development).

Biological activity assays

We offer a range of biological activity assays in vito and in vivo to determine the activity of peptides and mimetics. We have established animal models of cancer, MS and hypertension as well as in vitro assays including but not limited to, CTL assays, profliferation assays, ELISA, ELISpot, cytokine assays, bioplex, gene arrays, flow cytometry.